Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials

AIMS: Primary prevention implantable cardioverter defibrillators (ICDs) are established therapy for reducing mortality in patients with left ventricular systolic dysfunction and ischaemic heart disease (IHD). However, their efficacy in patients without IHD has been controversial. We undertook a meta...

Descripción completa

Detalles Bibliográficos
Autores principales: Shun-Shin, Matthew J., Zheng, Sean L., Cole, Graham D., Howard, James P., Whinnett, Zachary I., Francis, Darrel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461475/
https://www.ncbi.nlm.nih.gov/pubmed/28329280
http://dx.doi.org/10.1093/eurheartj/ehx028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5461475/
https://www.ncbi.nlm.nih.gov/pubmed/28329280
http://dx.doi.org/10.1093/eurheartj/ehx028

Ejemplares similares